Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$672,322
+$404,459 QoQ
Shares Held
9,356
+312.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#728
of 1,408 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2025CallValue
$3,408,255
CallShares
20,700
PutValue
$345,765
PutShares
2,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SIG BROKERAGE, LP holds $7,382,863 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (9.1% of the industry book) .
All Filings in ZTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $672,322 | 9,356 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $267,863 | 2,266 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $423,006 | 3,362 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $932,643 | 6,374 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,150,911 | 7,380 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $345,765 | 2,100 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $3,408,255 | 20,700 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $1,886,230 | 11,456 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,377,736 | 8,456 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $1,498,956 | 9,200 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $1,629,300 | 10,000 | Put | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||